Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Correction: Behavioral and synaptic alterations relevant to obsessivecompulsive disorder in mice with increased EAAT3 expression.

Delgado-Acevedo C, Estay SF, Radke AK, Sengupta A, Escobar AP, Henríquez-Belmar F, Reyes CA, Haro-Acuña V, Utreras E, Sotomayor-Zárate R, Cho A, Wendland JR, Kulkarni AB, Holmes A, Murphy DL, Chávez AE, Moya PR.

Neuropsychopharmacology. 2019 May;44(6):1177. doi: 10.1038/s41386-019-0331-x.

2.

Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Delgado-Acevedo C, Estay SF, Radke AK, Sengupta A, Escobar AP, Henríquez-Belmar F, Reyes CA, Haro-Acuña V, Utreras E, Sotomayor-Zárate R, Cho A, Wendland JR, Kulkarni AB, Holmes A, Murphy DL, Chávez AE, Moya PR.

Neuropsychopharmacology. 2019 May;44(6):1163-1173. doi: 10.1038/s41386-018-0302-7. Epub 2018 Dec 26. Erratum in: Neuropsychopharmacology. 2019 Feb 21;:.

PMID:
30622300
3.

Dennis Luke Murphy, M.D. (1936-2017).

Moya PR, Wendland JR, Fox MA.

Genes Brain Behav. 2018 Mar;17(3):e12455. doi: 10.1111/gbb.12455. No abstract available.

PMID:
29596735
4.

Neonatal exposure to oestradiol increases dopaminergic transmission in nucleus accumbens and morphine-induced conditioned place preference in adult female rats.

Bonansco C, Martínez-Pinto J, Silva RA, Velásquez VB, Martorell A, Selva MV, Espinosa P, Moya PR, Cruz G, Andrés ME, Sotomayor-Zárate R.

J Neuroendocrinol. 2018 Jul;30(7):e12574. doi: 10.1111/jne.12574.

PMID:
29377365
5.

Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice.

González LF, Henríquez-Belmar F, Delgado-Acevedo C, Cisternas-Olmedo M, Arriagada G, Sotomayor-Zárate R, Murphy DL, Moya PR.

Biol Res. 2017 Sep 19;50(1):29. doi: 10.1186/s40659-017-0138-3.

6.

Amphetamine treatment affects the extra-hypothalamic vasopressinergic system in a sex- and nucleus-dependent manner.

Ahumada C, Bahamondes C, Cerda CA, Silva RA, Cruz G, Moya PR, Sotomayor-Zárate R, Renard GM.

J Neuroendocrinol. 2017 Apr;29(4). doi: 10.1111/jne.12465.

PMID:
28235136
7.

Connecting Synaptic Activity with Plasticity-Related Gene Expression: From Molecular Mechanisms to Neurological Disorders.

Muñoz P, Aschrafi A, Moya PR.

Neural Plast. 2016;2016:7149527. doi: 10.1155/2016/7149527. Epub 2016 Mar 20. No abstract available.

8.

Programming of Dopaminergic Neurons by Neonatal Sex Hormone Exposure: Effects on Dopamine Content and Tyrosine Hydroxylase Expression in Adult Male Rats.

Espinosa P, Silva RA, Sanguinetti NK, Venegas FC, Riquelme R, González LF, Cruz G, Renard GM, Moya PR, Sotomayor-Zárate R.

Neural Plast. 2016;2016:4569785. doi: 10.1155/2016/4569785. Epub 2016 Jan 10.

9.

Alcohol odor elicits appetitive facial expressions in human neonates prenatally exposed to the drug.

Faas AE, March SM, Moya PR, Molina JC.

Physiol Behav. 2015 Sep 1;148:78-86. doi: 10.1016/j.physbeh.2015.02.031. Epub 2015 Feb 21.

PMID:
25707382
10.

Improving amphetamine therapeutic selectivity: N,N-dimethyl-MTA has dopaminergic effects and does not produce aortic contraction.

Sotomayor-Zárate R, Jara P, Araos P, Vinet R, Quiroz G, Renard GM, Espinosa P, Hurtado-Guzmán C, Moya PR, Iturriaga-Vásquez P, Gysling K, Reyes-Parada M.

Basic Clin Pharmacol Toxicol. 2014 May;114(5):395-9. doi: 10.1111/bcpt.12168. Epub 2013 Dec 7.

11.

Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.

Moya PR, Wendland JR, Rubenstein LM, Timpano KR, Heiman GA, Tischfield JA, King RA, Andrews AM, Ramamoorthy S, McMahon FJ, Murphy DL.

Mov Disord. 2013 Aug;28(9):1263-70. doi: 10.1002/mds.25460. Epub 2013 Apr 29.

12.

Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1.

Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O'Dushlaine C, Fagerness JA, Yu D, Scharf JM, Chan E, Kassam F, Moya PR, Wendland JR, Delorme R, Richter MA, Kennedy JL, Veenstra-VanderWeele J, Samuels J, Greenberg BD, McCracken JT, Knowles JA, Fyer AJ, Rauch SL, Riddle MA, Grados MA, Bienvenu OJ, Cullen B, Wang Y, Shugart YY, Piacentini J, Rasmussen S, Nestadt G, Murphy DL, Jenike MA, Cook EH, Pauls DL, Hanna GL, Mathews CA.

Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):367-79. doi: 10.1002/ajmg.b.32137. Epub 2013 Apr 18.

PMID:
23606572
13.

Neonatal responsiveness to the odor of amniotic fluid.

Faas AE, Resino CF, Moya PR.

Arch Argent Pediatr. 2013 Apr;111(2):105-9. doi: 10.1590/S0325-00752013000200004. English, Spanish.

14.

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120435. doi: 10.1098/rstb.2012.0435. Print 2013. Review.

15.

Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes.

Moya PR, Dodman NH, Timpano KR, Rubenstein LM, Rana Z, Fried RL, Reichardt LF, Heiman GA, Tischfield JA, King RA, Galdzicka M, Ginns EI, Wendland JR.

Eur J Hum Genet. 2013 Aug;21(8):850-4. doi: 10.1038/ejhg.2012.245. Epub 2013 Jan 16.

16.

In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities.

Khaibullina A, Kenyon N, Guptill V, Quezado MM, Wang L, Koziol D, Wesley R, Moya PR, Zhang Z, Saha A, Mukherjee AB, Quezado ZM.

PLoS One. 2012;7(11):e48733. doi: 10.1371/journal.pone.0048733. Epub 2012 Nov 6.

17.

Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans.

Fox MA, Panessiti MG, Moya PR, Tolliver TJ, Chen K, Shih JC, Murphy DL.

Pharmacogenomics J. 2013 Dec;13(6):551-7. doi: 10.1038/tpj.2012.35. Epub 2012 Sep 11.

18.

4-Methylthioamphetamine increases dopamine in the rat striatum and has rewarding effects in vivo.

Sotomayor-Zárate R, Quiroz G, Araya KA, Abarca J, Ibáñez MR, Montecinos A, Guajardo C, Núñez G, Fierro A, Moya PR, Iturriaga-Vásquez P, Gómez-Molina C, Gysling K, Reyes-Parada M.

Basic Clin Pharmacol Toxicol. 2012 Dec;111(6):371-9. doi: 10.1111/j.1742-7843.2012.00926.x. Epub 2012 Aug 31.

19.

miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells.

Moya PR, Wendland JR, Salemme J, Fried RL, Murphy DL.

Int J Neuropsychopharmacol. 2013 Apr;16(3):621-9. doi: 10.1017/S1461145712000454. Epub 2012 May 8.

PMID:
22564678
20.

Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.

Moya PR, Fox MA, Jensen CL, Laporte JL, French HT, Wendland JR, Murphy DL.

BMC Pharmacol. 2011 Apr 7;11:3. doi: 10.1186/1471-2210-11-3.

21.
22.

A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study.

Liu X, Cannon DM, Akula N, Moya PR, Knudsen GM, Arentzen TE, Steele J, Laje G, Drevets WC, McMahon FJ.

Mol Psychiatry. 2011 Jun;16(6):584-5. doi: 10.1038/mp.2011.1. Epub 2011 Feb 22. No abstract available.

23.

Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.

Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG, Leeds P, Chuang DM.

Int J Neuropsychopharmacol. 2011 Jun;14(5):711-7. doi: 10.1017/S1461145710000726. Epub 2010 Jul 7.

24.

Increased gene expression of diacylglycerol kinase η in bipolar disorder.

Moya PR, Murphy DL, McMahon FJ, Wendland JR.

Int J Neuropsychopharmacol. 2010 Sep;13(8):1127-8. doi: 10.1017/S1461145710000593. Epub 2010 Jun 2. No abstract available.

25.

A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren-Patterson RF, Murphy DL.

Arch Gen Psychiatry. 2009 Apr;66(4):408-16. doi: 10.1001/archgenpsychiatry.2009.6.

26.

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR.

Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Review.

27.

N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.

Gobbi M, Funicello M, Gerstbrein K, Holy M, Moya PR, Sotomayor R, Forray MI, Gysling K, Paluzzi S, Bonanno G, Reyes-Parada M, Sitte HH, Mennini T.

J Neurochem. 2008 Jun;105(5):1770-80. doi: 10.1111/j.1471-4159.2008.05272.x. Epub 2008 Feb 4.

28.

A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder.

Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR, Murphy DL.

Hum Mol Genet. 2008 Mar 1;17(5):717-23. Epub 2007 Nov 30.

PMID:
18055562
29.

Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.

Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP.

J Pharmacol Exp Ther. 2007 Jun;321(3):1054-61. Epub 2007 Mar 2.

PMID:
17337633
30.

Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.

Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP.

Br J Pharmacol. 2002 Jun;136(4):510-9.

31.

Differential responsiveness to alcohol odor in human neonates: effects of maternal consumption during gestation.

Faas AE, Spontón ED, Moya PR, Molina JC.

Alcohol. 2000 Aug;22(1):7-17.

PMID:
11109023
32.

[Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].

Moya PR, Trombotto GT.

Medicina (B Aires). 1988;48(5):487-91. Spanish. No abstract available.

PMID:
3151216
33.

[Treatment of Chagas' disease with nifurtimox during the first months of life].

Moya PR, Paolasso RD, Blanco S, Lapasset M, Sanmartino C, Basso B, Moretti E, Cura D.

Medicina (B Aires). 1985;45(5):553-8. Spanish. No abstract available.

PMID:
3939553
34.

[Congenital Chagas disease: anatomopathological findings in the placenta and umbilical cord].

Moya PR, Villagra L, Risco J.

Rev Fac Cien Med Univ Nac Cordoba. 1979 Jan-Dec;37(1-4):21-7. Spanish. No abstract available.

PMID:
122217

Supplemental Content

Support Center